Ivermectin: A Ray of Hope in Africa’s Fight Against Malaria
Ivermectin: A Ray of Hope in Africa’s Fight Against Malaria
By Martin Donkor | August 2025
Published on Beyond Clinics Health Blog
Share This Article:
🔵 Facebook | 🐦 Twitter | 🟢 WhatsApp | ✉️ Email
Image credit: Unsplash
For as long as I can remember growing up in Adjoafua, in the Western-North region of Ghana, malaria has been a constant threat. Nets, sprays, and medicines have helped, but the mosquitoes keep coming. That’s why new research on ivermectin, a familiar deworming pill, feels both surprising and exciting—it might finally tip the scale.
So, What Is Ivermectin Really?
I remember my grandmother using ivermectin to treat skin parasites and worms. It felt almost magical—not just a medicine but a family safeguard. What few people know is that ivermectin may also kill mosquitoes that bite treated people, by making their blood deadly to the insects. It’s like giving mosquitoes a one-way ticket out of the transmission chain.
Real Results from Kenyan Communities
According to a 2025 study published by the New York Post, community-based trials in Kenya involving over 20,000 children administered monthly ivermectin doses during peak malaria season. The outcome? A 26% drop in malaria infections, even in areas with high net usage. The results shocked health experts—because they weren’t expecting it to work this well alongside existing tools.
Image credit: Unsplash
Unexpected Perks Beyond Malaria
Interestingly, families whose children received ivermectin also saw drops in lice and scabies infections. While minor, these benefits matter to rural families. And crucially, no severe side effects were reported—just mild, temporary symptoms like dizziness in some cases.
Practical and Scalable
Ivermectin is a simple oral pill—no refrigeration, injections, or expensive logistics. For rural Ghanaian towns where healthcare access is limited, this makes ivermectin a game-changer. Even if just 25% of a village takes the pill during the rainy season, models show community-level reductions in malaria transmission.
What This Means for Ghana
In Ghana’s underserved communities where bed net usage is inconsistent or mosquito resistance is growing, ivermectin could offer supplemental protection. Imagine health volunteers going door-to-door with pills during community outreach—low-cost and effective. With proper planning and oversight, Ghana can adapt this strategy to local contexts.
Looking Ahead
No single tool will end malaria in Africa. But ivermectin adds a new layer of defense that integrates well with existing tools like nets, vaccines, and sanitation. It’s human-centered, scalable, and practical. If research continues to show promise, this humble deworming drug may become a quiet hero in Africa’s malaria story.
About the Author
Martin Donkor is a public health advocate and BSc Biological Science graduate from AAMUSTED (Ghana), with a prior Diploma in Public Health. He’s passionate about disease surveillance, rural outreach, and scientific health communication. He has participated in malaria and onchocerciasis control campaigns and currently researches maternal malaria prevention practices in rural Ghana.
- 🔗 ORCID ID: https://orcid.org/0009-0000-9271-2619
- 📸 Instagram: @beyondclinics7
- 💼 LinkedIn: Martin Donkor
- 📧 Email: beyondclinics7@gmail.com
Disclaimer
This article is for informational purposes only and is not a substitute for professional medical advice. Always consult with qualified healthcare providers regarding any medical concerns. The views expressed are those of the author and do not constitute medical endorsements. Use of ivermectin should follow national health guidelines and clinical recommendations.
Join the conversation